Killer yeasts exert anti-plasmodial activities against the malaria parasite Plasmodium berghei in the vector mosquito Anopheles stephensi and in mice.
Anopheles stephensi
Killer toxin
Malaria
Plasmodium berghei
Symbiotic control
Wickerhamomyces anomalus
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
02 Jul 2019
02 Jul 2019
Historique:
received:
06
02
2019
accepted:
27
06
2019
entrez:
4
7
2019
pubmed:
4
7
2019
medline:
14
8
2019
Statut:
epublish
Résumé
Wickerhamomyces anomalus is a yeast associated with different insects including mosquitoes, where it is proposed to be involved in symbiotic relationships with hosts. Different symbiotic strains of W. anomalus display a killer phenotype mediated by protein toxins with broad-spectrum antimicrobial activities. In particular, a killer toxin purified from a W. anomalus strain (WaF17.12), previously isolated from the malaria vector mosquito Anopheles stephensi, has shown strong in vitro anti-plasmodial activity against early sporogonic stages of the murine malaria parasite Plasmodium berghei. Here, we provide evidence that WaF17.12 cultures, properly stimulated to induce the expression of the killer toxin, can directly affect in vitro P. berghei early sporogonic stages, causing membrane damage and parasite death. Moreover, we demonstrated by in vivo studies that mosquito dietary supplementation with activated WaF17.12 cells interfere with ookinete development in the midgut of An. stephensi. Besides the anti-sporogonic action of WaF17.12, an inhibitory effect of purified WaF17.12-killer toxin was observed on erythrocytic stages of P. berghei, with a consequent reduction of parasitaemia in mice. The preliminary safety tests on murine cell lines showed no side effects. Our findings demonstrate the anti-plasmodial activity of WaF17.12 against different developmental stages of P. berghei. New studies on P. falciparum are needed to evaluate the use of killer yeasts as innovative tools in the symbiotic control of malaria.
Sections du résumé
BACKGROUND
BACKGROUND
Wickerhamomyces anomalus is a yeast associated with different insects including mosquitoes, where it is proposed to be involved in symbiotic relationships with hosts. Different symbiotic strains of W. anomalus display a killer phenotype mediated by protein toxins with broad-spectrum antimicrobial activities. In particular, a killer toxin purified from a W. anomalus strain (WaF17.12), previously isolated from the malaria vector mosquito Anopheles stephensi, has shown strong in vitro anti-plasmodial activity against early sporogonic stages of the murine malaria parasite Plasmodium berghei.
RESULTS
RESULTS
Here, we provide evidence that WaF17.12 cultures, properly stimulated to induce the expression of the killer toxin, can directly affect in vitro P. berghei early sporogonic stages, causing membrane damage and parasite death. Moreover, we demonstrated by in vivo studies that mosquito dietary supplementation with activated WaF17.12 cells interfere with ookinete development in the midgut of An. stephensi. Besides the anti-sporogonic action of WaF17.12, an inhibitory effect of purified WaF17.12-killer toxin was observed on erythrocytic stages of P. berghei, with a consequent reduction of parasitaemia in mice. The preliminary safety tests on murine cell lines showed no side effects.
CONCLUSIONS
CONCLUSIONS
Our findings demonstrate the anti-plasmodial activity of WaF17.12 against different developmental stages of P. berghei. New studies on P. falciparum are needed to evaluate the use of killer yeasts as innovative tools in the symbiotic control of malaria.
Identifiants
pubmed: 31266522
doi: 10.1186/s13071-019-3587-4
pii: 10.1186/s13071-019-3587-4
pmc: PMC6604151
doi:
Substances chimiques
Antimalarials
0
Mycotoxins
0
Types de publication
Journal Article
Langues
eng
Pagination
329Subventions
Organisme : European Research Council
ID : 842429
Pays : International
Organisme : Horizon 2020- ERC POC 2018
ID : 842429
Références
J Antimicrob Chemother. 2002 Jun;49(6):961-71
pubmed: 12039888
Cell Microbiol. 2004 Jul;6(7):671-85
pubmed: 15186403
Insect Biochem Mol Biol. 2004 Jul;34(7):667-71
pubmed: 15242707
Exp Parasitol. 2007 Aug;116(4):346-53
pubmed: 17376436
Proc Natl Acad Sci U S A. 2007 May 22;104(21):9047-51
pubmed: 17502606
Trends Biotechnol. 2007 Aug;25(8):338-42
pubmed: 17576018
Front Biosci. 2008 May 01;13:6920-37
pubmed: 18508705
Antonie Van Leeuwenhoek. 2011 Jan;99(1):25-34
pubmed: 20706871
Antonie Van Leeuwenhoek. 2011 Jan;99(1):113-9
pubmed: 21086043
Antonie Van Leeuwenhoek. 2011 Jan;99(1):43-50
pubmed: 21113816
Environ Microbiol. 2011 Apr;13(4):911-21
pubmed: 21208355
Antonie Van Leeuwenhoek. 2011 Jan;99(1):93-105
pubmed: 21222032
Science. 2011 Feb 25;331(6020):1074-7
pubmed: 21350178
Lancet Infect Dis. 2011 Dec;11(12):925-32
pubmed: 21856232
Appl Environ Microbiol. 2012 Jan;78(1):292-4
pubmed: 22020520
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12734-9
pubmed: 22802646
PLoS One. 2012;7(7):e41893
pubmed: 22848648
Malar J. 2012 Nov 05;11:366
pubmed: 23126583
Pathog Glob Health. 2012 Nov;106(7):380-5
pubmed: 23265608
Trends Biotechnol. 2013 Mar;31(3):185-93
pubmed: 23395485
Sci Rep. 2013;3:1706
pubmed: 23609325
J Innate Immun. 2014;6(2):169-81
pubmed: 23988482
PLoS One. 2014 May 01;9(5):e95988
pubmed: 24788884
Med Vet Entomol. 2016 Mar;30(1):101-6
pubmed: 26542209
Microb Ecol. 2016 Apr;71(3):747-60
pubmed: 26573833
Malar J. 2016 Jan 11;15:21
pubmed: 26754943
Malar J. 2016 Aug 30;15(1):440
pubmed: 27577697
Environ Microbiol Rep. 2017 Oct;9(5):642-648
pubmed: 28714286
Front Microbiol. 2018 Apr 20;9:753
pubmed: 29731744
Evid Based Complement Alternat Med. 2018 May 24;2018:6859632
pubmed: 29977316
Cell. 1996 Sep 20;86(6):973-83
pubmed: 8808632
Clin Diagn Lab Immunol. 1997 Mar;4(2):142-6
pubmed: 9067647